Clinical Trial Update: Alefacept Mechanism of Action in Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial update describing the mechanism of action of alefacept in psoriasis after the study was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Alefacept (Alefacept)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Psoriasis | Phase 2 | Status: COMPLETED